Cannabidiol Modulates M-Type K+ and Hyperpolarization-Activated Cation Currents

Article type: Research Article

Keywords: cannabidiol (CBD), M-type K, hyperpolarization-activated cation current, voltage-gated Na, pituitary cell

Authors: Yen-Chin Liu ⚬, Edmund Cheung So ⚬, Sheng-Nan Wu ⚬

Affiliations: Department of Anesthesiology, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan; anesliu@kmu.edu.tw; Department of Anesthesiology, School of Post-Baccalaureate, College of Medicine, Kaohsiung Medical University, Kaohsiung 80756, Taiwan; Department of Anesthesiology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan; Department of Anesthesia, An-Nan Hospital, China Medical University, Tainan 70965, Taiwan; Department of Physiology, National Cheng Kung University Medical College, Tainan 70101, Taiwan; School of Medicine, National Sun-Yat Sen University College of Medicine, Kaohsiung 80424, Taiwan; Department of Research and Education, An-Nan Hospital, China Medical University, Tainan 70965, Taiwan

License: © 2023 by the authors. CC BY 4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Article links: DOI: 10.3390/biomedicines11102651  |  PubMed: 37893024  |  PMC: PMC10604323

Relevance: Relevant: mentioned in keywords or abstract

Full text: PDF (3.2 MB)

1. Introduction

Cannabidiol (CBD) is a non-psychoactive cannabinoid derived from the Cannabis plant, known for its potential therapeutic effects. It is among over 100 cannabinoids present in the plant and has been shown to be effective in treating various medical conditions, such as epilepsy, bipolar disorder, inflammation, and cancer [ref. 1,ref. 2,ref. 3,ref. 4,ref. 5]. Recent studies have demonstrated that CBD can modify the activity in the hypothalamic–pituitary–adrenal axis [ref. 6,ref. 7] and can modulate different types of transmembrane ionic currents in electrically excitable cells, including the voltage-gated Na⁺ current (I_Na) and the M-type K⁺ currents (I_K(M)) [ref. 5,ref. 8,ref. 9]. Thus, further clarification is necessary to determine the effects of CBD or related compounds on ionic currents present in the membranes of electrically excitable cells.

The KCNQ2, KCNQ3, and KCNQ5 genes encode the core subunits of K_V7.2, K_V7.3, and K_V7.5 channels, respectively [ref. 10]. These potassium (K⁺) channels, when activated, generate the M-type K⁺ current (I_K(M)), which is characterized by its low threshold voltage activation and by slow activation and deactivation properties [ref. 11,ref. 12]. The modulation of I_K(M) has gained significant recognition as an additional therapeutic approach for treating a range of neurological disorders characterized by excessive neuronal activity. These disorders encompass conditions like cognitive dysfunction, neuropathic pain, and epilepsy [ref. 10,ref. 13,ref. 14,ref. 15]. Furthermore, the magnitude of I_K(M) is believed to regulate the availability of voltage-gated Na⁺ (Na_V) channels during prolonged high-frequency firing [ref. 16]. Previous studies have shown that CBD can modify the magnitude of I_K(M) [ref. 9,ref. 17]. However, it is still largely unclear whether and how exposure to CBD can perturb the magnitude or gating properties of I_K(M).

The hyperpolarization-activated cation current (I_h), also known as the “funny current” (I_f), plays a crucial role in regulating repetitive electrical activity in cardiac cells, various types of central neurons, and endocrine or neuroendocrine cells [ref. 11,ref. 18,ref. 19,ref. 20,ref. 21]. This ionic current exhibits unique characteristics, including slow voltage-dependent activation kinetics and a mixed Na⁺/K⁺ current that flows inwardly, and it can be blocked by CsCl or ivabradine [ref. 20,ref. 22]. Activation of I_h may lead to depolarization of the resting potential, reaching the threshold required for generating or triggering an action potential. Consequently, it influences pacemaker activity and impulse propagation [ref. 22]. Additionally, the slow kinetics of I_h in response to prolonged hyperpolarization can result in long-lasting, activity-dependent modulation of membrane excitability across various types of excitable cells [ref. 23]. I_h is mediated by channels encoded by members of the hyperpolarization-activated cyclic-nucleotide-gated (HCN) gene family, and studies have demonstrated that the activity of these channels underlies the ionic mechanisms associated with both convulsive disorders and inflammatory pain disorders [ref. 24,ref. 25,ref. 26].

Therefore, based on the aforementioned information, our aim was to investigate the effects of CBD or other related compounds on perturbations in various ionic currents (such as I_Na, I_K(M), I_h, and I_K(erg)) in pituitary GH₃ cells. The findings from this study highlight the evidence showing that CBD can directly and effectively inhibit the magnitude of I_K(M) and I_h in a concentration- and voltage-dependent manner. Such suppression of ionic currents appears to be direct and is highly unlikely to be linked to its binding to cannabinoid receptors.

2. Materials and Methods

2.1. Chemicals, Drugs, and Solutions Used for This Work

Cannabidiol (CBD, 2-[(1R,6R)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol) and cannabichromene were acquired from Sigma-Aldrich (Cerilliant Corp., Darmstadt, Germany). Linopirdine (Lino), naloxone, NS1643, oxaliplatin (OXAL), tefluthrin (Tef), tetraethylammonium chloride (TEA), tetrodotoxin (TTX), and thyrotropin-releasing hormone (TRH) were supplied by Sigma-Aldrich (Merck, Darmstadt, Germany). Liraglutinide was obtained from Novo Nordisk^® (Bagsværd, Denmark), telmisartan (TEL) was obtained from Tocris (Bristol, UK), and liraglutinide (Saxenda^®) was obtained from MedChemExpress (Genechain, Kaohsiung, Taiwan).

Unless stated otherwise, the cell culture materials, such as Ham’s F-12 medium, L-glutamine, horse serum, and fetal calf serum, were obtained from HyClone^TM (Thermo Fisher; Level Biotech, Tainan, Taiwan). All other chemicals and reagents, such as CdCl₂, CsCl, CsOH, HEPES, and aspartic acid, were commercially available and of analytical reagent grade.

The HEPES-buffered normal Tyrode’s solution used in this study had the following composition (in mM): NaCl 136.5, KCl 5.4, CaCl₂ 1.8, MgCl₂ 0.53, glucose 5.5, and HEPES-NaOH buffer 5.5 (pH 7.4). For recording I_h, I_K(M), or I_K(erg), the recording pipettes were filled up with the following solution (in mM): K-aspartate 130, KCl 20, KH₂PO₄ 1, MgCl₂ 1, EGTA 0.1, Na₂ATP 3, Na₂GTP 0.1, and HEPES-KOH buffer 5 (pH 7.2). To measure whole-cell I_K(M) or I_K(erg), high-K⁺ bathing solution was used with the following composition (in mM): KCl 145, MgCl₂ 0.53, and HEPES-KOH 5 (pH 7.4). All solutions were prepared using deionized water obtained from a Milli-Q^® water purification system (APS Water Services, Inc., Van Nuys, CA, USA). On the day of use, the pipette solution and culture media were filtered through an Acrodisc^® syringe filter with 0.2 μm of Supor^® membrane (Palll Bio-Check, Tainan, Taiwan).

2.2. Preparation of Pituitary GH₃ Cells

GH₃ pituitary tumor cells, originally derived from ATCC [CCL-82^TM] and obtained from the Bioresources Collection and Research Center (BCRC-60015) in Hsinchu, Taiwan, were cultured in Ham’s F-12 medium supplemented with 15% (v/v) horse serum, 2.5% (v/v) fetal calf serum, and 2 mM L-glutamine in a humidified environment with 5% CO₂/95% air [ref. 19]. The verification of GH₃ cells was conducted by measuring the level of prolactin in the culture medium. Experiments were conducted 5 to 6 days after the cells had reached 60–80% confluence.

2.3. Electrophysiological Recordings Using Patch-Clamp Technique

The GH₃ cells were dispersed just before each measurement with care. Then, a small amount of the cell suspension was rapidly transferred to a custom-made chamber, where the cells were allowed to settle on the bottom surface. A DM-IL inverted microscope (Leica; Highrise Instrument, Taichung, Taiwan) was used to monitor cell size during the experiments. A custom-made chamber was tightly placed on the microscope’s stage, and a video camera system with a magnification of 1500× was connected to the microscope. The cells that were examined were maintained in a bath of normal Tyrode’s solution with a concentration of 1.8 mM CaCl₂, at room temperature (20–25 °C).

The patch electrodes were meticulously fashioned from Kimax-51 capillaries with an outer diameter of 1.5–1.8 mm (#34500; Kimble, Dogger, New Taipei City, Taiwan) using a two-stage PP-830 puller (Narishige; Taiwan Instrument, Tainan, Taiwan). The electrode tips were then fire-polished using an MF-83 microforge (Narishige). Typically, the filled electrodes had tip resistances ranging from 2 to 4 MΩ. For standard patch-clamp recordings in a modified whole-cell configuration [ref. 19,ref. 20], we employed an RK-400 patch amplifier (Bio-Logic, Claix, France). The cell capacitance was measured to be 34 ± 6 pA (n = 32). Junction potentials, which arise at the electrode tip due to differences in composition between the internal solution and the bath solution, were nullified shortly before establishing a seal formation. Junction potential corrections were subsequently applied to the whole-cell data. During the recording process, the signal output data (i.e., potential or current tracings) were acquired and stored online at a frequency of 10 kHz or higher kHz. This was achieved using an ASUSPRO-BN401 LG laptop computer (ASUS, Yuan-Dai, Tainan, Taiwan) equipped with a Digidata 1440A (Molecular Devices; Advanced Biotech, New Taipei City, Taiwan). The entire system was controlled by pClamp 10.6 software (Molecular Devices).

2.4. Analyses of Whole-Cell Recordings

We analyzed the concentration–response curves of CBD-induced inhibition on the density of I_K(M) or I_h in GH₃ cells. To elicit the slowly activating I_K(M), cells were placed in high-K⁺, Ca²⁺-free solution, and we applied a 1 s depolarizing pulse to −10 mV from a holding potential of −50 mV, as described previously [ref. 11]. The current densities were measured at the end of the depolarizing pulse in the presence or absence of exposure to different CBD concentrations. To evoke I_h, cells were bathed in Ca²⁺-free Tyrode’s solution and subjected to a 2 s hyperpolarizing pulse to −110 mV from a holding potential of −40 mV. The I_h density was measured with or without CBD at the end of the hyperpolarizing pulse. The concentration of CBD needed to inhibit 50% of the I_K(M) or I_h (i.e., IC₅₀) was approximated using a Hill function as follows:

where [CBD] is the CBD concentration applied, IC₅₀ is the half-maximal concentration of CBD, n_H is the Hill coefficient, and E_max is the maximal decrease in I_K(M) or I_h caused by the CBD presence.

To analyze the steady activation curve of I_K(M) or I_h in the absence and presence of CBD, we fitted the data using a Boltzmann function. The Boltzmann equation is defined as:

where G_max is the maximal conductance of either I_K(M) or I_h acquired from the absence or presence of 3 μM CBD, and V and V_1/2 represent the membrane potential in mV and the half-point of the activation curve of I_K(M) or I_h, respectively. The slope factor of the activation of I_K(M) or I_h is represented by k.

2.5. Methods for Curve-Fitting and Statistical Analyses

Continuous curves were fitted to the experimental data using linear or nonlinear regression methods, such as exponential or sigmoidal function. The software tools used for this purpose included pClamp 10.6 software (Molecular Devices), 64-bit OriginPro 2022b software (OriginLab^®; Scientific Formosa, Kaohsiung, Taiwan), and Microsoft Excel (part of the Microsoft 365 suite) (Microsoft, Redmond, WA, USA) with the “Solver” add-in function.

The experimental data obtained from the experiments comprised various types of ionic currents and were presented using the mean value with corresponding standard error of the mean (SEM). The sample size (n) denoted the number of cells from which data were gathered, and the SEM error bars were included in the plots. The Kolmogorov–Smirnov test for normality suggested that the data distribution was acceptable and could be assumed as normal. Paired or unpaired Student’s t-tests between the two groups were applied. To assess differences between more than two groups, we used an analysis of variance (ANOVA-1 or ANOVA-2) with or without repeated measures, followed by a post-hoc Fisher’s least significant difference test. Differences were considered statistically significant at a p value < 0.05 (* or ** in the figures denote significance).

3. Results

3.1. Effect of Cannabidiol (CBD) on the M-Type K⁺ Current (I_K(M)) Identified in Pituitary GH₃ Cells

In the initial whole-cell current recordings, we first investigated whether CBD had an effect on the density of I_K(M) in these cells. To assess whether CBD caused any perturbations in I_K(M), we exposed the cells to a high-K⁺, Ca²⁺-free solution containing 1 μM tetrodotoxin (TTX). The measuring electrode was filled with a K⁺-enriched solution, and we then held the examined cell at the level of −50 mV, and a 1 s depolarizing pulse to −10 mV was applied to evoke I_K(M). Under the experimental conditions described above, the activation of I_K(M) was indicated by a slowly activating time course in response to long-lasting step depolarization. As the reversal potential of K⁺ ions was around 0 mV, the resulting I_K(M) was a slowly activating inward K⁺ current that directed the flow of K⁺ ions into the interior of the cell [ref. 11,ref. 12]. Of interest, we observed a progressive reduction in the density of I_K(M) following a 1 s membrane depolarization from −50 to −10 mV. This reduction was observed one minute after cells were subjected to the increasing concentrations of CBD (Figure 1A). For instance, when cells were exposed to 1 or 3 μM CBD, the density of I_K(M) measured at the end of a 1 s membrane depolarization decreased to 3.8 ± 0.4 pA/pF (n = 8, p < 0.05) or 1.9 ± 0.2 pA/pF (n = 8, p < 0.05), respectively, from a control value of 3.9 ± 0.4 pA/pF (n = 8). Following the cessation of CBD exposure and subsequent washout, the current density returned to 3.7 ± 0.3 pA/pF (n = 8). Additionally, Figure 1B displays the concentration–response curve for the CBD-induced inhibition of the density of I_K(M), which was constructed with an IC₅₀ value of 3.6 μM. The results reflect that exposing GH₃ cells to CBD can cause a concentration-dependent decrease in the density of I_K(M), indicating a depressant action.

3.2. Effect of CBD on the Current Density Versus Voltage Relationship and the Quasi-Steady-State Activation Curve of I_K(M) in GH₃ Cells

To further investigate the inhibitory effect of CBD on I_K(M), we analyzed the current density versus voltage relationship of I_K(M) with and without CBD addition. Figure 2A illustrates the quasi-steady-state current density versus voltage relationship of I_K(M) obtained during the control period and after exposure to 3 μM CBD in these cells. We observed a marked decrease in the density of I_K(M) elicited by depolarizing steps, particularly at voltage levels ranging between −30 and −10 mV, upon the addition of CBD.

Moreover, the quasi-steady-state activation curve of I_K(M) in the absence and presence of 3 μM CBD was constructed and plotted in Figure 2B. The normalized conductance of I_K(M) with or without the presence of CBD was fitted to a Boltzmann function using the method described in Section 2. In the control, V_1/2 = −17.5 ± 0.8 mV, k = 4.9 ± 0.5 (n = 7), while in the presence of 3 μM CBD, V_1/2 = −10.4 ± 0.8 mV, k = 4.9 ± 0.5 (n = 7). The data reflected that CBD not only decreased the maximal magnitude of I_K(M), but it also shifted the quasi-steady-state activation curve of I_K(M) to more depolarized potential (i.e., in the rightward direction) by approximately 7 mV. However, we found no clear adjustments in the slope factor (k value or steepness) of the curve when exposed to CBD, suggesting that there was no change in the gating charge of the curve during its exposure. Alternatively, the CBD-induced inhibition of I_K(M) in unclamped cells could depend on the pre-existing resting membrane.

3.3. Comparisons among Effects of CBD, CBD plus Naloxone, Linopirdine (Lino), Thyrotropin-Releasing Hormone (TRH), and Liraglutinide (Lira) on the Density of I_K(M) in GH₃ Cells

In another series of whole-cell experiments, we tested the possible effects of CBD, CBD plus naloxone, Lino, TRH, and Lira on the density of I_K(M) elicited by membrane depolarization from −50 to −10 mV. Lino has been demonstrated to inhibit I_K(M) potently [ref. 27], while TRH can suppress the magnitude of I_K(M) [ref. 11]. Lira was known to be an agonist of glucagon-like peptide-1 (GLP-1) receptor [ref. 28,ref. 29]. As demonstrated in Figure 3A,B, CBD at a concentration of 3 μM produced an inhibitory effect on the I_K(M) density; however, a subsequent addition of 10 μM naloxone failed to counteract CBD-induced inhibition of I_K(M). Meanwhile, the presence of Lino (3 μM), TRH (1 μM), or Lira (1 μM) was effective at suppressing the magnitude of I_K(M) (Figure 3B). Naloxone is known to block opioid receptors. Naloxone at a concentration of 30 μM also did not cause any effect on the CBD-induced decrease in I_K(M). Hence, similar to TRH, Lira can suppress I_K(M) possibly through its binding to GLP-1 receptors in pituitary cells [ref. 28]. However, further addition of naloxone exerted no effect on the CBD-mediated decrease in I_K(M), suggesting that the CBD effect on I_K(M) is independent of binding to opioid receptors.

3.4. Modification by CBD of I_K(M) Elicited by Pulse-Train (PT) Stimulation

Previous work has shown the capability of I_K(M) to maintain the availability of voltage-gated Na⁺ (Na_V) channels during prolonged high-frequency firing [ref. 16]. Therefore, we further examined whether the CBD presence may modify the extent of I_K(M) during PT depolarizing stimuli from −50 to −10 mV in GH₃ cells. As depicted in Figure 4, a one-minute exposure to 3 μM CBD resulted in a reduction in the density of both activating and deactivating I_K(M) during 1 s PT stimulation. For instance, the presence of CBD (3 μM) decreased the density of activating I_K(M) from 7.0 ± 1.1 to 3.7 ± 0.6 pA/pF (n = 7, p < 0.05) and the density of deactivating I_K(M) from 25.8 ± 3.8 to 7.7 ± 1.2 pA/pF (n = 7, p < 0.05). Subsequent to the washout of the CBD, the densities of activating and deactivating I_K(M) were restored to 6.8 ± 0.9 (n = 6) and 24.9 ± 3.5 pA/pF (n = 6), respectively. The obtained data provided insights into the persistent effectiveness of CBD-induced inhibition of I_K(M) even under conditions of high PT stimulation. Thus, it is plausible to consider that the presence of Na_V channels during high-frequency firing in unclamped excitable cells may experience additional inhibition during CBD exposure, despite CBD’s previously descried potential to suppress Na_V channel activity [ref. 8].

3.5. Mild Inhibitory Effect of CBD on the erg-Mediated K⁺ Current (I_K(erg)) in GH₃ Cells

We continued by exploring whether CBD can exert any effect on another type of K⁺ currents (i.e., I_K(erg)) enriched in these cells. Cells were kept in high-K⁺, Ca²⁺-free solution and we filled up the measuring electrode with K⁺-enriched solution. To evoke I_K(erg), we held the tested cell at the level of −10 mV and a hyperpolarizing step to −90 mV for a duration of 1 s was applied to it. As shown in Figure 5, one minute after being exposed to CBD (10 μM), the density of I_K(erg) in response to membrane hyperpolarization was significantly decreased to 8.6 ± 1.1 pA/pF (n = 8, p < 0.05) from a control value of 11.2 ± 1.5 pA/pF (n = 8), while CBD at a concentration of 3 μM did not have a clear effect on I_K(erg) density elicited by membrane hyperpolarization. Following the removal of the 10 μM CBD and subsequent washout, the I_K(erg) density returned to 11.0 ± 1.4 pA/pF (n = 8). Moreover, during continued exposure to 10 μM CBD, a further addition of NS1643 (10 μM) was capable of attenuating CBD-mediated inhibition of I_K(erg) (10.9 ± 1.5 pA/pF, n = 8, p < 0.05) in these cells. NS1643 has been reported to stimulate I_K(erg) [ref. 30]. The results therefore indicate that exposure to CBD slightly suppressed the density of I_K(erg) in GH₃ cells.

3.6. Failure of CBD Effect on Voltage-Gated Na⁺ Current (I_Na) in GH₃ Cells

CBD was recently reported to suppress the magnitude of Na_V1.4-encoded I_Na [ref. 8]. In our study, we conducted additional experiments to investigate whether the presence of CBD can also modify I_Na in GH₃ cells. As shown in Figure 6, in whole-cell current recordings, the magnitude of I_Na elicited in response to a short depolarizing pulse to −10 from a holding potential of −100 mV was robustly observed; however, the I_Na density remained unaltered during a 2 min continued exposure to 10 μM CBD. Similarly, cannabichromene, a compound known to bind to cannabinoid receptor 1 [ref. 1], did not have any effect on the density of I_Na. Moreover, with continued presence of 10 μM CBD, the further addition of ranolazine (Ran, 10 μM) was effective at suppressing I_Na density, while the addition of either tefluthrin (Tef, 10 μM) or telmisartan (TEL, 10 μM) enhanced current density. Ran is an inhibitor of late I_Na [ref. 31], while Tef or TEL can stimulate I_Na effectively [ref. 32]. Therefore, unlike Na_V1.4-encoded currents [ref. 8], the I_Na observed in GH₃ cells appears to be resistant to modulation by CBD.

3.7. Effect of CBD on Hyperpolarization-Activated Cation Current (I_h) Measured in GH₃ Cells

We continued to examine the perturbations caused by CBD in I_h in these cells. To investigate the effects of CBD on I_h, we performed experiments under specific conditions. First, we placed the cells in Ca²⁺-free Tyrode’s solution containing 0.5 mM CdCl₂ and 1 μM TTX. We used CdCl₂ and TTX to block voltage-gated Ca²⁺ and Na⁺ currents, respectively. The measuring electrode was backfilled with K⁺-enriched internal solution to evoke I_h. As the whole-cell mode was established, the tested cell was maintained at the level of −40 mV in voltage-clamp mode, and the voltage steps were subsequently applied (2 s in duration) to a series of voltages ranging between −110 and −20 mV in 10 mV increments. As demonstrated in Figure 7A, one minute after cells were exposed to 3 μM CBD, the I_h density elicited by 2 s membrane hyperpolarization to −110 mV from a holding potential of −40 mV was decreased. However, even with continued exposure to 3 μM CBD, the subsequent addition of 10 μM naloxone failed to reverse the CBD-induced decrease in I_h density. Moreover, the quasi-steady-state current remained largely unaltered during CBD exposure.

Of interest, one minute after cell exposure to 3 μM CBD, the density of I_h evoked by the 2 s long step hyperpolarization progressively decreased (Figure 7B,C). For instance, at the levels of −100 and −110 mV, it was observed that following a one-minute exposure to 3 μM CBD, the density of I_h diminished to 4.6 ± 0.8 pA/pF (n = 7, p < 0.05) and 7.6 ± 1.1 pA/pF (n = 7, p < 0.05), respectively. These values were reduced from the control values of 9.7 ± 1.4 pA/pF (n = 7) and 15.6 ± 1.7 pA/pF (n = 7). When CBD was removed, the I_h density at −100 and −110 mV returned to 9.3 ± 1.1 pA/pF (n = 7) and 15.2 ± 1.6 pA/pF (n = 7), respectively. Additionally, the activating time constant (τ_act) of I_h activated by the 2 s hyperpolarizing step from −40 to −110 mV decreased to 1.81 ± 0.04 s (n = 7, p < 0.05) from a control value of 1.07 ± 0.03 s (n =7). Moreover, with continued exposure to 3 μM CBD, a further addition of naloxone (10 μM) failed to reverse the CBD-mediated decrease in I_h density.

Figure 7D illustrates the quasi-steady-state activation curve of I_h acquired in the control period and during exposure to 3 μM CBD. According to the least-squares minimization procedure, the best fitting parameters (i.e., V_1/2 and k) for such a steady-state activation curve of the current were convergently acquired with or without the addition of CBD. In the presence of 3 μM CBD, the value of V_1/2 for the activation curve of the current was −101 ± 4 mV (n = 7), which was significantly distinguishable from that in the control period, −89 ± 4 mV (n = 7, p < 0.05). However, the k values in the absence (7.2 ± 0.3, n = 7) and presence of 3 μM CBD (7.3 ± 0.3, n = 7, p > 0.05) did not differ significantly. The experimental results showed that during exposure to 3 μM CBD, the activation curve of I_h was shifted toward more hyperpolarized potential with no change in the slope factor of the curve (i.e., the steepness of the activation curve). Therefore, it appears likely that no change in the gating charge of I_h activation curve was altered by CBD exposure. The responsiveness of I_h to CBD is influenced by varying levels of pre-existing resting membrane potential.

As illustrated in Figure 7E, the presence of various concentrations of CBD can suppress the density of I_h in a concentration-dependent manner. By virtue of a non-linear least-squares fit to the experimental data, the IC₅₀ value for the inhibitory effect of CBD on I_h was 3.3 μM, a value that is similar to that needed to suppress I_K(M) density described above. These results indicate that CBD can exercise a depressant action on I_h elicited by membrane hyperpolarization in these cells.

3.8. Effect of CBD on the Hysteretic Behavior (i.e., Voltage-Dependent Hysteresis (Hys_(V))) of I_h Elicited by Isosceles-Triangular Ramp Voltage (V_ramp) in GH₃ Cells

Previous work has demonstrated the effectiveness of I_h’s Hys_(V) strength in affecting either various patterns of bursting firing or action potential configuration in varying types of excitable cells [ref. 33,ref. 34]. Therefore, we continued by determining whether and how the presence of CBD may adjust the I_h strength activated in response to long-lasting triangular V_ramp. In this series of experiments, in the control period (i.e., absence of CBD), we maintained the tested cell at the level of −40 mV, and an upsloping (forward) limb from −150 to −40 mV followed by a downsloping (backward) limb back to −150 mV (i.e., upright isosceles-triangular V_ramp) for a total duration of 2 s with a ramp speed of ±55 mV/s was thereafter applied to evoke I_h’s hysteresis (Hys_(V)) (Figure 8A,B). In accordance with previous studies [ref. 21,ref. 33,ref. 34], the Hys_(V) of I_h in response to such double V_ramp was robustly observed and sensitive to suppression by ivabradine (IVA), an inhibitor of I_h [ref. 19,ref. 20,ref. 26]. Of additional interest, upon cell exposure to 3 μM CBD, the strength of I_h’s Hys_(V) responding to both rising and falling limbs of double V_ramp progressively became depressed (Figure 8C). For instance, as the triangular V_ramp was applied, the value of ∆area (i.e., the difference in area enclosed by the curve in the forward and backward direction) for Hys_(V) in the control period was 248 ± 52 mV·(pA/pF) (n = 7), while the ∆area value of I_h in the presence of 3 μM CBD was significantly reduced to 142 ± 28 mV·(pA/pF) (n = 7, p < 0.05). Moreover, a subsequent addition of oxaliplatin (OXAL, 10 μM) effectively reversed the CBD-induced decrease in Hys_(V)’s strength. OXAL has been reported to activate I_h [ref. 25,ref. 35]. Therefore, the results indicate that cell exposure to CBD can modify the magnitude and gating properties of I_h observed in GH₃ cells.

4. Discussion

This study identified seven significant findings. (1) Cannabinoid (CBD) exposure resulted in a concentration-dependent suppression of M-type K⁺ current (I_K(M)) in pituitary GH₃ cells, with an IC₅₀ of 3.6 μM. (2) The presence of CBD caused a rightward shift in the quasi-steady-state activation curve of I_K(M) without changes in the slope factor (i.e., k value) of the curve. (3) The CBD-induced block of I_K(M) was not reversible by further addition of naloxone. (4) CBD exposure also suppressed I_K(M) elicited by pulse-train (PT) depolarizing stimuli. (5) CBD slightly reduced the magnitude of erg-mediated K⁺ current (I_K(erg)) but did not affect voltage-gated Na⁺ current (I_Na) in GH₃ cells. (6) Cell exposure to CBD resulted in the inhibition of hyperpolarization-activated cation current (I_h) with an IC₅₀ of 3.3 μM. (7) The quasi-steady-state activation curve of I_h was shifted to a more hyperpolarized potential without changes in the curve’s slope factor. Based on the findings of this study, it can be inferred that CBD exerts a significant impact on transmembrane ionic currents, particularly I_K(M) and I_h. Assuming that these effects would occur in vivo, they would likely influence the firing frequency of action potential generation in cells. Therefore, further research is necessary to determine the possible mechanisms of action of CBD or other structurally similar compounds in the body, such as the anxiolytic effects [ref. 3,ref. 6,ref. 7].

Different to some extent from a previous study [ref. 17], the current study found that the presence of CBD could suppress the magnitude of I_K(M). The IC₅₀ value for CBD to inhibit the density of I_K(M) in GH₃ cells was 3.6 μM. The quasi-steady-state activation curve of I_K(M) in GH₃ cells shifted towards a more depolarized potential, without changes in the curve’s steepness. Additionally, the CBD presence could suppress the I_K(M) elicited by PT stimulation. These findings suggest that the responsiveness of I_K(M) in unclamped cells is influenced by various confounding factors, including the level of the pre-existing resting membrane potential, CBD concentration, patterns of action potential firing, or combinations of these variables.

It needs to be mentioned that, concerning the steady-state activation curve of I_K(M), it is important to have a sufficiently long step duration to accurately assess the slope factor and V_1/2 values. This is essential for a more precise determination of the activation curve of this current, followed by the application of the Boltzmann equation to deduce V_1/2 and the slope factor, subsequently allowing to predict the gating charge value. However, in the cells we have investigated (such as GH₃ cells), when we employed a voltage-clamp protocol that exceeds 1 sec, we often observed the appearance of the inactivation process from other types of K⁺ currents. This phenomenon, to a certain extent, led to confusion with the inactivation of other delayed-rectifier K⁺ currents. The primary reason behind this is that GH₃ cells, in addition to I_K(M), still possess various types of delayed-rectifier K⁺ currents. This is a common issue encountered when conducting experiments on native excitable cells. Using cells with KCNQx-encoded currents may help mitigate these complications. Nonetheless, the exposure of CBD to GH₃ cells did suppress the strength of I_K(M) and shift the quasi-steady-state activation curve of I_K(M) to a more depolarized potential without affecting the curve’s slope factor.

Previous research has shown that a train of depolarizing pulses can effectively alter the magnitude of I_Na, which is a current that decays exponentially over time [ref. 16]. More recently, it has been demonstrated that the magnitude of I_K(M) can regulate the availability of Na_V channels during prolonged high-frequency firing [ref. 16]. In our study, we found that exposure of GH₃ cells to CBD suppressed the magnitude of I_K(M) during PT depolarizing stimuli. As a result, the availability of Na_V channels during sustained high-frequency firing may be reduced, leading to a decrease in reliable presynaptic spiking and synaptic transmission at high frequencies [ref. 9,ref. 10,ref. 14].

Our study observed that CBD did not significantly alter the magnitude of I_Na in GH₃ cells, nor did cannabichromene, an agonist of cannabinoid receptor 1 [ref. 1]. These results appear to differ from the findings of a previous study conducted by Huang et al. [ref. 8]. They reported the suppression of the density of Na_V1.4 currents by CBD. The reason for this discrepancy is not yet understood; however, it is possible that Na_V1.4 currents affected by CBD [ref. 8] are primarily expressed in skeletal muscle cells rather than endocrine or neuroendocrine cells. It is thus pertinent to conduct further investigation to determine if the effects of CBD on I_Na are specific to certain tissues.

Four mammalian isoforms of HCN, which are HCN1, HCN2, HCN3, and HCN4, make up the macroscopic I_h (or I_f) [ref. 22,ref. 33]. Among them, HCN2, HCN3, and a combination of HCN2 and HCN3 channels are highly expressed in GH₃ cells and other types of endocrine or neuroendocrine cells [ref. 36]. In our study, we observed that CBD caused a suppressive effect on I_h in a concentration- and voltage-dependent manner. The IC₅₀ value for CBD to suppress I_h was estimated as 3.3 μM, and the quasi-steady-state activation curve of I_h was shifted to a more hyperpolarizing potential with no changes in the curve’s steepness. The CBD exposure also resulted in a considerable reduction in the strength of I_h’s Hys_(V) elicited by long-lasting triangular V_ramp. The effect of CBD on this Hys_(V) behavior would be linked to its effect on the gating mechanism of HCN channels [ref. 37,ref. 38]. Therefore, apart from its effectiveness in inhibiting I_K(M), as detailed above, CBD can also induce changes in the magnitude, gating kinetics, and Hys_(V) behavior of I_h in a manner that may have pharmacological, therapeutic, or toxicological significance. It is worth noting that clinically achievable levels of CBD have been reported [ref. 39].

It is important to mention that, as CBD affects ion channels on the cell membrane with similar potency, it appears unlikely that these effects are solely mediated by CBD binding to cannabinoid receptors. If these effects were due largely to binding to cannabinoid receptors, the specificity of the effects should be particularly evident. Indeed, the subsequent addition of naloxone, an antagonist of opioid receptors, was not found to reverse CBD-induced inhibition of I_K(M), despite the ability of CBD to modulate the activity of μ- and δ-opioid receptors [ref. 4,ref. 40]. Therefore, CBD’s influence on these currents is likely to be rapid and direct, rather than dependent on binding to cannabinoid or opioid receptors. Our findings offer substantial promise in terms of utilizing CBD in fundamental neuroscience and clinical research. As for how CBD modulates ionic currents and potentially disrupts specific downstream signaling pathways, further in-depth research is warranted in the future.

References

1. A.C. Howlett, M.E. Abood. CB(1) and CB(2) Receptor Pharmacology. Adv. Pharmacol., 2017. [DOI | PubMed]
2. A.I. Fraguas-Sánchez, A.I. Torres-Suárez. Medical Use of Cannabinoids. Drugs, 2018. [DOI | PubMed]
3. L.D. Schurman, D. Lu, D.A. Kendall, A.C. Howlett, A.H. Lichtman. Molecular Mechanism and Cannabinoid Pharmacology. Handb. Exp. Pharmacol., 2020. [DOI | PubMed]
4. S.C. Britch, S. Babalonis, S.L. Walsh. Cannabidiol: Pharmacology and therapeutic targets. Psychopharmacology, 2021. [DOI | PubMed]
5. M.R. Ghovanloo, P.C. Ruben. Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications. Neuroscientist, 2022. [DOI | PubMed]
6. A. Viudez-Martínez, M.S. García-Gutiérrez, J. Manzanares. Cannabidiol regulates the expression of hypothalamus-pituitary-adrenal axis-related genes in response to acute restraint stress. J. Psychopharmacol., 2018. [DOI | PubMed]
7. A.L. Lopresti, S.J. Smith, P.D. Drummond. Modulation of the hypothalamic-pituitary-adrenal (HPA) axis by plants and phytonutrients: A systematic review of human trials. Nutr. Neurosci., 2022. [DOI | PubMed]
8. C.W. Huang, P.C. Lin, J.L. Chen, M.J. Lee. Cannabidiol Selectively Binds to the Voltage-Gated Sodium Channel Na(v)1.4 in Its Slow-Inactivated State and Inhibits Sodium Current. Biomedicines, 2021. [DOI | PubMed]
9. X. Zhan, C. Drummond-Main, D. Greening, J. Yao, S.W.R. Chen, J.P. Appendino, P.Y.B. Au, R.W. Turner. Cannabidiol counters the effects of a dominant-negative pathogenic Kv7.2 variant. iScience, 2022. [DOI | PubMed]
10. F. Miceli, M.V. Soldovieri, M. Martire, M. Taglialatela. Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. Curr. Opin. Pharmacol., 2008. [DOI | PubMed]
11. S. Sankaranarayanan, S.M. Simasko. Characterization of an M-like current modulated by thyrotropin-releasing hormone in normal rat lactotrophs. J. Neurosci., 1996. [DOI | PubMed]
12. A.A. Selyanko, J.K. Hadley, I.C. Wood, F.C. Abogadie, P. Delmas, N.J. Buckley, B. London, D.A. Brown. Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell. J. Neurosci., 1999. [DOI | PubMed]
13. V.K. Gribkoff. The therapeutic potential of neuronal KCNQ channel modulators. Expert Opin. Ther. Targets, 2003. [DOI | PubMed]
14. B.C. Baculis, J. Zhang, H.J. Chung. The Role of K(v)7 Channels in Neural Plasticity and Behavior. Front. Physiol., 2020. [DOI | PubMed]
15. P. Nappi, F. Miceli, M.V. Soldovieri, P. Ambrosino, V. Barrese, M. Taglialatela. Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction. Pflügers Arch. Eur. J. Physiol., 2020. [DOI | PubMed]
16. Y. Zhang, D. Li, Y. Darwish, X. Fu, L.O. Trussell, H. Huang. KCNQ Channels Enable Reliable Presynaptic Spiking and Synaptic Transmission at High Frequency. J. Neurosci., 2022. [DOI | PubMed]
17. H.B. Zhang, L. Heckman, Z. Niday, S. Jo, A. Fujita, J. Shim, R. Pandey, H. Al Jandal, S. Jayakar, L.B. Barrett. Cannabidiol activates neuronal Kv7 channels. eLife, 2022. [DOI | PubMed]
18. H. Irisawa, H.F. Brown, W. Giles. Cardiac pacemaking in the sinoatrial node. Physiol. Rev., 1993. [DOI | PubMed]
19. Y.C. Liu, Y.J. Wang, P.Y. Wu, S.N. Wu. Tramadol-induced block of hyperpolarization-activated cation current in rat pituitary lactotrophs. Naunyn-Schmiedeberg’s Arch. Pharmacol., 2009. [DOI | PubMed]
20. H.T. Hsiao, Y.C. Liu, P.Y. Liu, S.N. Wu. Concerted suppression of I(h) and activation of I(K(M)) by ivabradine, an HCN-channel inhibitor, in pituitary cells and hippocampal neurons. Brain Res. Bull., 2019. [DOI | PubMed]
21. C.W. Chuang, K.P. Chang, H.Y. Cho, T.H. Chuang, M.C. Yu, C.L. Wu, S.N. Wu. Characterization of Inhibitory Capability on Hyperpolarization-Activated Cation Current Caused by Lutein (β,ε-Carotene-3,3’-Diol), a Dietary Xanthophyll Carotenoid. Int. J. Mol. Sci., 2022. [DOI | PubMed]
22. C.H. Peters, R.K. Singh, J.R. Bankston, C. Proenza. Regulation of HCN Channels by Protein Interactions. Front. Physiol., 2022. [DOI | PubMed]
23. T. Mäki-Marttunen, V. Mäki-Marttunen. Excitatory and inhibitory effects of HCN channel modulation on excitability of layer V pyramidal cells. PLoS Comput. Biol., 2022. [DOI | PubMed]
24. R. Surges, M. Kukley, A. Brewster, C. Rüschenschmidt, J. Schramm, T.Z. Baram, H. Beck, D. Dietrich. Hyperpolarization-activated cation current Ih of dentate gyrus granule cells is upregulated in human and rat temporal lobe epilepsy. Biochem. Biophys. Res. Commun., 2012. [DOI | PubMed]
25. Z. Yongning, L. Xianguang, C. Hengling, C. Su, L. Fang, L. Chenhong. The hyperpolarization-activated cyclic nucleotide-gated channel currents contribute to oxaliplatin-induced hyperexcitability of DRG neurons. Somatosens. Mot. Res., 2021. [DOI | PubMed]
26. N. Ohashi, D. Uta, M. Ohashi, H. Baba. Analgesic effect of ivabradine against inflammatory pain mediated by hyperpolarization-activated cyclic nucleotide-gated cation channels expressed on primary afferent terminals in the spinal dorsal horn. Pain, 2022. [DOI | PubMed]
27. M. Noda, M. Obana, N. Akaike. Inhibition of M-type K+ current by linopirdine, a neurotransmitter-release enhancer, in NG108-15 neuronal cells and rat cerebral neurons in culture. Brain Res., 1998. [DOI | PubMed]
28. R.L. Dods, D. Donnelly. The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling. Biosci. Rep., 2015. [DOI | PubMed]
29. D.J. Drucker. GLP-1 physiology informs the pharmacotherapy of obesity. Mol. Metab., 2022. [DOI | PubMed]
30. O. Casis, S.P. Olesen, M.C. Sanguinetti. Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol. Pharmacol., 2006. [DOI | PubMed]
31. B.S. Chen, Y.C. Lo, H. Peng, T.I. Hsu, S.N. Wu. Effects of ranolazine, a novel anti-anginal drug, on ion currents and membrane potential in pituitary tumor GH(3) cells and NG108-15 neuronal cells. J. Pharmacol. Sci., 2009. [DOI | PubMed]
32. E.C. So, S.N. Wu, Y.C. Lo, K. Su. Differential regulation of tefluthrin and telmisartan on the gating charges of I(Na) activation and inactivation as well as on resurgent and persistent I(Na) in a pituitary cell line (GH(3)). Toxicol. Lett., 2018. [DOI | PubMed]
33. R. Männikkö, S. Pandey, H.P. Larsson, F. Elinder. Hysteresis in the voltage dependence of HCN channels: Conversion between two modes affects pacemaker properties. J. Gen. Physiol., 2005. [DOI | PubMed]
34. Y.F. Xiao, N. Chandler, H. Dobrzynski, E.S. Richardson, E.M. Tenbroek, J.J. Wilhelm, V. Sharma, A. Varghese, M.R. Boyett, P.A. Iaizzo. Hysteresis in human HCN4 channels: A crucial feature potentially affecting sinoatrial node pacemaking. Sheng Li Xue Bao, 2010. [PubMed]
35. W.T. Chang, Z.H. Gao, S.W. Li, P.Y. Liu, Y.C. Lo, S.N. Wu. Characterization in Dual Activation by Oxaliplatin, a Platinum-Based Chemotherapeutic Agent of Hyperpolarization-Activated Cation and Electroporation-Induced Currents. Int. J. Mol. Sci., 2020. [DOI | PubMed]
36. K. Kretschmannova, A.E. Gonzalez-Iglesias, M. Tomić, S.S. Stojilkovic. Dependence of hyperpolarisation-activated cyclic nucleotide-gated channel activity on basal cyclic adenosine monophosphate production in spontaneously firing GH3 cells. J. Neuroendocrinol., 2006. [DOI | PubMed]
37. R.B. Robinson, S.A. Siegelbaum. Hyperpolarization-activated cation currents: From molecules to physiological function. Annu. Rev. Physiol., 2003. [DOI | PubMed]
38. R. Ramentol, M.E. Perez, H.P. Larsson. Gating mechanism of hyperpolarization-activated HCN pacemaker channels. Nat. Commun., 2020. [DOI | PubMed]
39. S.A. Millar, N.L. Stone, A.S. Yates, S.E. O’Sullivan. A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Front. Pharmacol., 2018. [DOI | PubMed]
40. M. Kathmann, K. Flau, A. Redmer, C. Tränkle, E. Schlicker. Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Naunyn Schmiedeberg’s Arch. Pharmacol., 2006. [DOI | PubMed]